Key result
Coronary microvascular dysfunction critically impacts the natural history and prognosis of pathologic LVH.
Why the study?
Coronary microvascular disease is considered to play an important role in pathologic cardiac hypertrophy, prompting a summary of current knowledge across its most frequent forms.
Coronary microvascular disease plays an important role in the natural history of hypertrophic and infiltrative cardiomyopathies, which can be assessed using non-invasive imaging like PET and CMR.
Pathologic hypertrophy of the cardiac muscle is a commonly encountered phenotype in clinical practice, associated with a variety of structural and non-structural diseases. Coronary microvascular disease is considered to play an important role in the natural history of this pathological phenotype. Non-invasive imaging modalities, most prominently positron emission tomography and cardiac magnetic resonance, have provided insights into the pathophysiological mechanisms of the interplay between hypertrophy and the coronary microvasculature. This article summarizes the current knowledge on coronary microvascular dysfunction in the most frequently encountered forms of pathologic hypertrophy.
No takes yet. Share an insight, caveat, or question.
Giannopoulos et al. (2022) conducted a review in Hypertrophic and infiltrative cardiomyopathies. Coronary microvascular dysfunction is a multifactorial condition that plays a critical role in the natural history and prognosis of pathologic left ventricular hypertrophy phenotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: